obs AS, Nieto FJ, Szklo M, Barnes R, Sharrett AR, Ko WJ. Risk
factors for popliteal and carotid wall thicknesses in the Atherosclerosis
Risk in Communities (ARIC) Study. Am J Epidemiol 1999;150:
1055-67.
110. Laakso M. Benefits of strict glucose and blood pressure control in type
2 diabetes: lessons from the UK Prospective Diabetes Study. Circulation 1999;99:461-2.
111. Action to Control Cardiovascular Risk in Diabetes Study Group,
Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al.
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med
2008;358:2545-59.
112. The ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose
control and vascular outcomes in patients with type 2 diabetes. N Engl
J Med 2008;358:2560-72.
113. Effect of simvastatin on coronary atheroma: the Multicentre AntiAtheroma Study (MAAS). Lancet 1994;344:633-8.
114. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum
cholesterol levels and six-year mortality from stroke in 350,977 men
screened for the multiple risk factor intervention trial. N Engl J Med
1989;320:904-10.
115. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire de Concalves A,
Inzitari D, et al. Total and HDL cholesterol and risk of stroke.
EUROSTROKE: a collaborative study among research centres in
Europe. J Epidemiol Comm Health 2002;56(suppl 1):i19-24.
116. Horenstein RB, Smith DE, Mosca L. Ch